Home › Colite ulcerosa › Texas › Lubbock
Studi clinici su Colite ulcerosa a Lubbock, TX
9 studi su Colite ulcerosa cercano partecipanti presso sedi a Lubbock e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
In reclutamentoFase 3
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
In reclutamentoFase 2
- GI Alliance - Lubbock /ID# 283920, Lubbock
- Caprock Gastro Research - Lubbock /ID# 283921, Lubbock
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
In reclutamentoFase 4
- West Texas Research Institute, Lubbock
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
In reclutamentoFase 1/2Volontari sani benvenuti
- Xencor Investigative Site, Lubbock
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
In reclutamentoFase 2
- Site US-015, Lubbock
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
In reclutamentoFase 2
- GI Alliance - Lubbock, Lubbock
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
In reclutamentoFase 3
- GI Alliance - Lubbock - Site Number: 8400092, Lubbock
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
In reclutamentoFase 3
- Texas Digestive Disease Consultants dba GI Alliance - Lubbock - Site Number: 8400092, Lubbock
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
In reclutamentoFase 2
- Mirador Therapeutics Selected Site, Lubbock
Studi su Colite ulcerosa in altre città
- New York City, NY23 studi
- Orlando, FL22 studi
- Miami, FL21 studi
- Houston, TX17 studi
- San Antonio, TX16 studi
- Chicago, IL15 studi
- Tacoma, WA15 studi
- San Diego, CA15 studi
- Tyler, TX14 studi
- Colorado Springs, CO14 studi
- Los Angeles, CA13 studi
- St. Louis, MO13 studi
Altri studi a Lubbock
- Malattia di Crohn10 studi
- Cancro al seno6 studi
- Cancro del polmone non a piccole cellule4 studi
- Artrite psoriasica3 studi
- Ictus3 studi
- Sovrappeso3 studi
- Obesità3 studi
- Malattia infiammatoria intestinale3 studi
- Linfoma di Burkitt3 studi
- Mieloma multiplo3 studi
Fonte: ClinicalTrials.gov, dati recuperati il 3 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.